Cephalon Drops Patent Suit Vs. Sandoz Over Provigil
Cephalon, Inc. has dropped its patent infringement suit against Swiss drug maker Sandoz following that drugmaker's decision not to market a generic version of Cephalon's drug Provigil....To view the full article, register now.
Already a subscriber? Click here to view full article